In our study, we showed that DHRS2 was down-regulated in the TAMR/MCF-7 cells, which suggests that decreased expression of DHRS2 is associate with tumor progression, wherein it acts by inhibiting p53 protein expression. The gene discussed is DHRS2; the disease is neoplasm.